HANetf announces that the HAN-GINS Indxx Healthcare Innovation UCITS ETF (WELL) will launch on London Stock Exchange, Borsa Italiana and XETRA in April, 2019 with a TER of 75bps…….
Hector McNeil, co-Founder and co-CEO, HANetf
WELL has been launched on HANetf’s unique, independent white-label UCITS ETF platform with Gins Global Index Funds, as part of a series of thematic ETFs that provide exposure to innovative and emerging industrial and technological themes.
|London Stock Exchange||WELL||HAWELL.L||IE00BJQTJ848||BJVBGL7||USD||Acc|
|London Stock Exchange||WELP||WELP.L||IE00BJQTJ848||BJVBGM8||GBP||Acc|
The new ETF tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index, enabling investors to gain exposure to companies at the forefront of healthcare innovation from both Developed and Emerging Markets.
To be included, constituents must generate a majority of their revenues from innovative healthtech sectors including Bioinformatics, Bioengineering, Genome Sequencing, Healthcare Trackers, Nanotechnology, Neuroscience, Robotics and Medical Devices.
The 88 current constituents have a combined market capitalisation of ~$824 Billon.
Anthony Ginsberg, Founder and Managing Director, Gins Global Index Funds, said: “Healthcare advances over the past 100 years have dramatically increased human lifespans and reduced the risk of death from communicable diseases like malaria or influenza.
Technology and healthcare are now combining to create a faster, safer and more personalised generation of diagnostics, treatments and medicines. We are excited to offer WELL with HANetf, providing exposure to the companies at the forefront of these developments in a diversified, liquid and transparent format.”
Hector McNeil, co-Founder and co-CEO, HANetf, said: “We are pleased to introduce WELL, expanding our range of HAN-GINS ETFs which enable investors to incorporate long-term, transformational technological trends into their portfolios.
Healthcare has been a core portfolio holding for decades, and with this new ETF, we go beyond ‘Big Pharma’ to capture the companies that are addressing the key healthcare and wellness challenges of our time. When it comes to healthcare, we hope all investors get WELL soon.”